ACET
Price
$0.62
Change
+$0.04 (+6.90%)
Updated
Apr 23, 04:51 PM (EDT)
Capitalization
48.1M
26 days until earnings call
ORGO
Price
$4.44
Change
+$0.11 (+2.54%)
Updated
Apr 23, 04:59 PM (EDT)
Capitalization
374.78M
14 days until earnings call
Ad is loading...

ACET vs ORGO

Header iconACET vs ORGO Comparison
Open Charts ACET vs ORGOBanner chart's image
Adicet Bio
Price$0.62
Change+$0.04 (+6.90%)
Volume$100
Capitalization48.1M
Organogenesis Holdings
Price$4.44
Change+$0.11 (+2.54%)
Volume$29.4K
Capitalization374.78M
ACET vs ORGO Comparison Chart
Loading...
ACET
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACET vs. ORGO commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACET is a Hold and ORGO is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 24, 2025
Stock price -- (ACET: $0.62 vs. ORGO: $4.44)
Brand notoriety: ACET and ORGO are both not notable
ACET represents the Biotechnology, while ORGO is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ACET: 38% vs. ORGO: 53%
Market capitalization -- ACET: $48.1M vs. ORGO: $374.78M
ACET [@Biotechnology] is valued at $48.1M. ORGO’s [@Pharmaceuticals: Other] market capitalization is $374.78M. The market cap for tickers in the [@Biotechnology] industry ranges from $266.85B to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.65B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACET’s FA Score shows that 1 FA rating(s) are green whileORGO’s FA Score has 1 green FA rating(s).

  • ACET’s FA Score: 1 green, 4 red.
  • ORGO’s FA Score: 1 green, 4 red.
According to our system of comparison, both ACET and ORGO are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACET’s TA Score shows that 4 TA indicator(s) are bullish while ORGO’s TA Score has 6 bullish TA indicator(s).

  • ACET’s TA Score: 4 bullish, 5 bearish.
  • ORGO’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, ORGO is a better buy in the short-term than ACET.

Price Growth

ACET (@Biotechnology) experienced а +7.82% price change this week, while ORGO (@Pharmaceuticals: Other) price change was +4.47% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.04%. For the same industry, the average monthly price growth was -8.89%, and the average quarterly price growth was -12.57%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.96%. For the same industry, the average monthly price growth was -6.07%, and the average quarterly price growth was -9.98%.

Reported Earning Dates

ACET is expected to report earnings on Aug 06, 2025.

ORGO is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+8.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Pharmaceuticals: Other (+2.96% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ORGO($375M) has a higher market cap than ACET($48.1M). ORGO YTD gains are higher at: 35.312 vs. ACET (-39.532). ORGO has higher annual earnings (EBITDA): 36M vs. ACET (-110.65M). ACET has more cash in the bank: 176M vs. ORGO (104M). ACET has less debt than ORGO: ACET (17.2M) vs ORGO (119M). ORGO has higher revenues than ACET: ORGO (433M) vs ACET (0).
ACETORGOACET / ORGO
Capitalization48.1M375M13%
EBITDA-110.65M36M-307%
Gain YTD-39.53235.312-112%
P/E RatioN/A70.25-
Revenue0433M-
Total Cash176M104M169%
Total Debt17.2M119M14%
FUNDAMENTALS RATINGS
ACET vs ORGO: Fundamental Ratings
ACET
ORGO
OUTLOOK RATING
1..100
6775
VALUATION
overvalued / fair valued / undervalued
1..100
36
Fair valued
74
Overvalued
PROFIT vs RISK RATING
1..100
10093
SMR RATING
1..100
9590
PRICE GROWTH RATING
1..100
9441
P/E GROWTH RATING
1..100
148
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ACET's Valuation (36) in the Medical Distributors industry is somewhat better than the same rating for ORGO (74) in the Financial Conglomerates industry. This means that ACET’s stock grew somewhat faster than ORGO’s over the last 12 months.

ORGO's Profit vs Risk Rating (93) in the Financial Conglomerates industry is in the same range as ACET (100) in the Medical Distributors industry. This means that ORGO’s stock grew similarly to ACET’s over the last 12 months.

ORGO's SMR Rating (90) in the Financial Conglomerates industry is in the same range as ACET (95) in the Medical Distributors industry. This means that ORGO’s stock grew similarly to ACET’s over the last 12 months.

ORGO's Price Growth Rating (41) in the Financial Conglomerates industry is somewhat better than the same rating for ACET (94) in the Medical Distributors industry. This means that ORGO’s stock grew somewhat faster than ACET’s over the last 12 months.

ORGO's P/E Growth Rating (8) in the Financial Conglomerates industry is in the same range as ACET (14) in the Medical Distributors industry. This means that ORGO’s stock grew similarly to ACET’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ACETORGO
RSI
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
89%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 10 days ago
78%
Declines
ODDS (%)
Bearish Trend 7 days ago
88%
Bearish Trend 3 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
73%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
ACET
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PENNX7.730.19
+2.52%
Royce Small-Cap Fund Invmt
FIGFX19.65N/A
N/A
Fidelity International Growth
KSCYX182.62N/A
N/A
Kinetics Small Cap Opportunities Inst
CHUCX21.56N/A
N/A
Alger Global Equity C
GCINX14.16N/A
N/A
Green Century MSCI Intl Indx Indvl Inv

ORGO and

Correlation & Price change

A.I.dvisor indicates that over the last year, ORGO has been loosely correlated with PRGO. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if ORGO jumps, then PRGO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORGO
1D Price
Change %
ORGO100%
+2.85%
PRGO - ORGO
47%
Loosely correlated
+1.85%
ANIP - ORGO
44%
Loosely correlated
+1.40%
AMRX - ORGO
32%
Poorly correlated
+1.68%
ACET - ORGO
29%
Poorly correlated
+2.34%
AMPH - ORGO
27%
Poorly correlated
+1.83%
More